Related Experiment Video
Updated: Jul 5, 2026
09:00
Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
Published on: April 17, 2026
MDM2 regulates dihydrofolate reductase activity through monoubiquitination
Maria Maguire1, Paul C Nield, Timothy Devling
1Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom.
Cancer Research
|May 3, 2008
Summary
MDM2, a cancer-associated protein, directly targets dihydrofolate reductase (DHFR), impacting folate metabolism and cell growth independently of p53. This discovery links MDM2
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- MDM2 is a crucial ubiquitin ligase known for regulating p53.
- MDM2 overexpression is linked to tumor progression, sometimes independent of p53.
- MDM2 targets proteins like MDM4 and RB1, affecting cell growth and proliferation.
Purpose of the Study:
- To identify novel substrates of the MDM2 ubiquitin ligase.
- To investigate the functional consequences of MDM2 interaction with its novel substrate.
- To explore the implications of this interaction in cancer biology and folate metabolism.
Main Methods:
- Direct binding assays to confirm MDM2-substrate interaction.
- Ubiquitination assays to determine the type of ubiquitination (mono- vs. polyubiquitination).
- Enzyme activity assays to measure substrate function.
- Cell-based assays to assess metabolic changes and drug sensitivity.
- Mutational analysis of MDM2 to identify critical functional domains.
Main Results:
- Dihydrofolate reductase (DHFR) was identified as a novel MDM2 substrate.
- MDM2 directly binds and monoubiquitinates DHFR.
- MDM2 reduces DHFR activity, impacting folate metabolism and methotrexate sensitivity, independent of p53.
- An intact MDM2 RING finger is essential for DHFR inhibition.
Conclusions:
- MDM2 directly regulates DHFR activity and folate metabolism through monoubiquitination.
- This p53-independent regulation has significant implications for cancer development.
- The study establishes a novel link between MDM2's ubiquitin ligase activity and one-carbon metabolism.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
01:17Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.